BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Business

  CohBar to Announce 2019 Third Quarter Financial Results and Provide Business Update on November 6, 2019

  CohBar, Inc. announced that the company will release its third quarter 2019 financial results after the market closes on Wednesday, November 6, 2019.

  October 24, 2019

   · 

  4 min read
• Pharm Country

  GSK announces new events in the “Us in Lupus” campaign to reach women of color

  GSK announced new events across communities in the U.S. to reach women of color living with lupus.

  October 24, 2019

   · 

  4 min read
• Business

  rMark Bio and West Monroe Partners Enter Multi-Year Strategic Partnership to Accelerate the Adoption of AI in Life Sciences

  The partnership brings together West Monroe’s deep business and technical experience with rMark Bio’s artificial intelligence platform.

  October 24, 2019

   · 

  3 min read
• Biotech Beach

  Amgen To Make Repatha® (evolocumab) Available Exclusively At Its Lower List Price Option In 2020

  Repatha Original List Price Option Will be Discontinued Effective Dec. 31, 2019 Almost Half of All Medicare Patients Will Have an Affordable, Low Fixed Copay in 2020

  October 24, 2019

   · 

  13 min read
• World first clinical trial commenced in alcohol use disorder

  A medication currently used to treat insomnia may also be effective in preventing alcohol intake and relapse in alcohol use disorder, according to researchers at the Florey Institute of Neuroscience and Mental Health.

  October 24, 2019

   · 

  2 min read
• Business

  Sonde Health Appoints David Liu as CEO

  Sonde Health Inc., a leading company developing a voice-based technology platform to measure health when a person speaks, announced that David Liu has joined Sonde as chief executive officer and a member of its board of directors.

  October 24, 2019

   · 

  4 min read
• Oblique Therapeutics Will be Presenting at the Inaugural RAS- Targeted Drug Discovery Europe Summit in Vienna in February 2020

  Oblique Therapeutics AB announces that Sreesha P Srinivasa is on the list of invited speakers who will be presenting at the RAS- Targeted Drug Discovery Europe Summit in Vienna in February 2020.

  October 24, 2019

   · 

  2 min read
• Business

  Genocea Provides Corporate Update and Reports Third Quarter 2019 Financial Results

  Genocea Biosciences, Inc., a biopharmaceutical company developing next-generation neoantigen immunotherapies, reported its operating and financial results for the quarter ended September 30, 2019.

  October 24, 2019

   · 

  6 min read
• Deals

  Pepticom Raises $5 Million in Series A Funding

  Pepticom, a leader in artificial intelligence peptide drug discovery, announced today that it has secured $5 million in Series A funding from the Chartered Group.

  October 24, 2019

   · 

  4 min read
• Drug Development

  MaxCyte Advances Phase I Clinical Trial of Lead CARMA™ mRNA-based Cell Therapy to Third Cohort of Patients

  CARMA platform offers faster manufacturing speeds, broader therapeutic applications, combination opportunities and repeat dosing potential

  October 24, 2019

   · 

  3 min read